Opportunities to improve opioid use disorder and infectious disease services: integrating responses to a dual epidemic
National Academies of Sciences, Medicine Division… - 2020 - books.google.com
Opioid use and infectious diseases are intertwined epidemics. Despite the fact that the
United States is more than two decades into the opioid crisis-the cause of tens of thousands …
United States is more than two decades into the opioid crisis-the cause of tens of thousands …
Management of opioid use disorder, opioid withdrawal, and opioid overdose prevention in hospitalized adults: A systematic review of existing guidelines
SL Calcaterra, R Bottner, M Martin… - Journal of hospital …, 2022 - Wiley Online Library
Background Hospitalizations related to the consequences of opioid use are rising. National
guidelines directing in‐hospital opioid use disorder (OUD) management do not exist. OUD …
guidelines directing in‐hospital opioid use disorder (OUD) management do not exist. OUD …
Coverage, formulary restrictions, and out-of-pocket costs for sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists in the Medicare …
J Luo, R Feldman, SD Rothenberger… - JAMA Network …, 2020 - jamanetwork.com
The Centers for Medicare & Medicaid Services recently announced a voluntary plan to cap
out-ofpocket costs associated with insulin products in participating enhanced Part D plans. 1 …
out-ofpocket costs associated with insulin products in participating enhanced Part D plans. 1 …
Pharmacy-related buprenorphine access barriers: an audit of pharmacies in counties with a high opioid overdose burden
Background Pharmacies sometimes restrict access to buprenorphine-naloxone
(buprenorphine) for individuals with opioid use disorder. The objective of this study was to …
(buprenorphine) for individuals with opioid use disorder. The objective of this study was to …
Buprenorphine Treatment By Primary Care Providers, Psychiatrists, Addiction Specialists, And Others: Trends in buprenorphine treatment by prescriber specialty …
Substantial increases in opioid-related morbidity and mortality have motivated the
implementation of federal policies to expand the buprenorphine prescribing capacity of …
implementation of federal policies to expand the buprenorphine prescribing capacity of …
Management of opioid use disorder and associated conditions among hospitalized adults: A Consensus Statement from the Society of Hospital Medicine
SL Calcaterra, M Martin, R Bottner… - Journal of hospital …, 2022 - Wiley Online Library
Hospital‐based clinicians frequently care for patients with opioid withdrawal or opioid use
disorder (OUD) and are well‐positioned to identify and initiate treatment for these patients …
disorder (OUD) and are well‐positioned to identify and initiate treatment for these patients …
[HTML][HTML] Coverage and prior authorization policies for medications for opioid use disorder in Medicaid managed care
Importance Medicaid is a key policy lever to improve opioid use disorder treatment, covering
approximately 40% of Americans with opioid use disorder. Although approximately 70% of …
approximately 40% of Americans with opioid use disorder. Although approximately 70% of …
[HTML][HTML] Buprenorphine use trends following removal of prior authorization policies for the treatment of opioid use disorder in 2 state Medicaid programs
Importance State Medicaid programs have implemented initiatives to expand treatment
coverage for opioid use disorder (OUD); however, some Medicaid programs still require …
coverage for opioid use disorder (OUD); however, some Medicaid programs still require …
Buprenorphine treatment for opioid use disorder: comparison of insurance restrictions, 2017–21: study examines insurance restrictions on buprenorphine treatment for …
Buprenorphine is a treatment medication that decreases mortality risks among people with
opioid use disorder (OUD). Despite its efficacy, buprenorphine is underused in the US …
opioid use disorder (OUD). Despite its efficacy, buprenorphine is underused in the US …
National trends in buprenorphine treatment for opioid use disorder from 2007 to 2018
Background: Buprenorphine is a key medication to treat opioid use disorder (OUD). Since its
approval in 2002, buprenorphine access has grown markedly, spurred by major federal and …
approval in 2002, buprenorphine access has grown markedly, spurred by major federal and …